Retinoblastoma Protein Contains a C-terminal Motif That Targets It for Phosphorylation by Cyclin-cdk Complexes

Retinoblastoma Protein Contains a C-terminal Motif That Targets It for Phosphorylation by Cyclin-cdk Complexes
复制标题

视网膜母细胞瘤蛋白含有一个 C 末端基序,可通过细胞周期蛋白-cdk 复合物对其进行磷酸化

DOI:
10.1128/mcb.19.2.1068
复制
发表时间:
1999
影响因子:
5.3
通讯作者:
William G. Kaelin
William G. Kaelin
中科院分区:
生物学2区
文献类型:
--
作者:
Peter D. Adams;Xiaotong Li;William R. Sellers;Kayla B. Baker;X. Leng;J. Wade Harper;Y. Taya;William G. Kaelin

文献摘要

参考文献

被引文献

相似文献

摘要 某些蛋白质(例如 E2F1 和 p21)与细胞周期蛋白-cdk2 复合物的稳定结合取决于包含核心序列 ZRXL 的保守细胞周期蛋白-cdk2 结合基序,其中 Z 和 X 通常是碱性的。细胞周期蛋白 A-cdk2 和细胞周期蛋白 E-cdk2 对视网膜母细胞瘤肿瘤抑制蛋白 pRB 的体外磷酸化被跨 E2F1 中存在的细胞周期蛋白-cdk2 结合基序的短肽抑制。对 pRB C 末端的检查表明它含有与 ZRXL 相关的序列元件。从残基 870 开始对这些序列之一进行定点诱变,会损害 pRB 的体外磷酸化。跨越该序列的合成肽也在体外抑制 pRB 的磷酸化。尽管存在完整的细胞周期蛋白-cdk 磷酸受体位点,但缺乏该序列的 pRB C 端截短突变体在体外和体内均被低磷酸化。通过与源自 pRB 的 ZRXL 样基序或与来自 E2F1 或 p21 的 ZRXL 基序融合,恢复此类突变体的磷酸化。磷酸位点特异性抗体显示,某些磷酸受体位点严格需要 C 端 ZRXL 基序,而至少一个位点不需要。此外,这种残留的磷酸化足以使 pRB 在体内失活,这意味着存在将细胞周期蛋白-cdk 复合物引导至 pRB 的其他机制。因此,pRB 的 C 末端含有 E2F1 和 p21 中发现的细胞周期蛋白 - cdk 相互作用基序,使其能够被细胞周期蛋白 - cdk 复合物识别和磷酸化。
ABSTRACT Stable association of certain proteins, such as E2F1 and p21, with cyclin-cdk2 complexes is dependent upon a conserved cyclin-cdk2 binding motif that contains the core sequence ZRXL, where Z and X are usually basic. In vitro phosphorylation of the retinoblastoma tumor suppressor protein, pRB, by cyclin A-cdk2 and cyclin E-cdk2 was inhibited by a short peptide spanning the cyclin-cdk2 binding motif present in E2F1. Examination of the pRB C terminus revealed that it contained sequence elements related to ZRXL. Site-directed mutagenesis of one of these sequences, beginning at residue 870, impaired the phosphorylation of pRB in vitro. A synthetic peptide spanning this sequence also inhibited the phosphorylation of pRB in vitro. pRB C-terminal truncation mutants lacking this sequence were hypophosphorylated in vitro and in vivo despite the presence of intact cyclin-cdk phosphoacceptor sites. Phosphorylation of such mutants was restored by fusion to the ZRXL-like motif derived from pRB or to the ZRXL motifs from E2F1 or p21. Phospho-site-specific antibodies revealed that certain phosphoacceptor sites strictly required a C-terminal ZRXL motif whereas at least one site did not. Furthermore, this residual phosphorylation was sufficient to inactivate pRB in vivo, implying that there are additional mechanisms for directing cyclin-cdk complexes to pRB. Thus, the C terminus of pRB contains a cyclin-cdk interaction motif of the type found in E2F1 and p21 that enables it to be recognized and phosphorylated by cyclin-cdk complexes.
DOI: 10.1101/gad.11.7.847
发表时间: 1997-04-01
影响因子: 10.5
作者:
LaBaer, J;Garrett, MD;Harlow, E
通讯作者: Harlow, E
DOI: 10.1101/gad.11.11.1479
发表时间: 1997-06-01
影响因子: 10.5
作者:
Lukas, J;Herzinger, T;Bartek, J
通讯作者: Bartek, J
DOI: --
发表时间: 1996-03
期刊: Oncogene
影响因子: 8
作者:
Y. Geng;E. Eaton;M. Picón;J. Roberts;A. Lundberg;A. Gifford;C. Sardet;R. Weinberg
通讯作者: Y. Geng;E. Eaton;M. Picón;J. Roberts;A. Lundberg;A. Gifford;C. Sardet;R. Weinberg
DOI: 10.1101/gad.8.15.1759
发表时间: 1994-08-01
影响因子: 10.5
作者:
HATAKEYAMA, M;BRILL, JA;WEINBERG, RA
通讯作者: WEINBERG, RA
DOI: 10.1101/gad.10.19.2505
发表时间: 1996-10-01
影响因子: 10.5
作者:
Duronio, RJ;Brook, A;OFarrell, PH
通讯作者: OFarrell, PH